JAKSTAT: Creating individualized therapy options and strategies to predict treatment response for patients with mature T-cell leukemias/lymphomas.
ERANETPLL: Implementating (epi)genetic and metabolic networks in the targeting of T-cell prolimphocytic leukemia.